抗癫痫发作药物对脂质代谢及动脉粥样硬化的长期影响
Long-Term Effects of Antiepileptic Drugs on Lipid Metabolism and Atherosclerosis
DOI: 10.12677/ACM.2023.133416, PDF,   
作者: 胡雨荣, 韩登峰*：新疆医科大学第一附属医院，新疆 乌鲁木齐
关键词: 癫痫；抗癫痫发作药物；血脂；动脉粥样硬化；Epilepsy； Antiepileptic Drugs； Blood Lipids； Atherosclerosis
摘要: 癫痫患者大都需要长期服药治疗甚至终生服药、联合用药。抗癫痫发作药物(ASM)已被证实对全身多系统均有一定的影响，应受到临床医生的关注。本文从ASM对脂质代谢及心脑血管系统的影响进行综述。
Abstract: Epilepsy patients mostly need long-term medication or even lifelong medication, combined medica-tion. Antiepileptic drugs (ASM) have been proved to have certain effects on multiple systems throughout the body, which should be paid more attention by clinicians. This paper reviews the ef-fects of ASM on lipid metabolism and cardiovascular and cerebrovascular system.
文章引用：胡雨荣, 韩登峰. 抗癫痫发作药物对脂质代谢及动脉粥样硬化的长期影响[J]. 临床医学进展, 2023, 13(3): 2938-2942. https://doi.org/10.12677/ACM.2023.133416

参考文献

[1] Thijs, R.D., Surges, R., O’Brien, T.J. and Sander, J.W. (2019) Epilepsy in Adults. The Lancet, 393, 689-701. [Google Scholar] [CrossRef] 
[2] Singh, A. and Trevick, S. (2016) The Epidemiology of Global Epilepsy. Neurologic Clinics, 34, 837-847. [Google Scholar] [CrossRef] [PubMed]
[3] Fiest, K.M., Sauro, K.M., Wiebe, S., et al. (2017) Prevalence and Incidence of Epilepsy: A Systematic Review and Meta-Analysis of International Studies. Neurology, 88, 296-303. [Google Scholar] [CrossRef] 
[4] Ali, R., Khan, M.A. and Siddiqui, N. (2015) Past, Present and Future of Antiepileptic Drug Therapy—Finding a Place for Heterocyclics. Mini-Reviews in Medicinal Chemistry, 15, 1024-1050. [Google Scholar] [CrossRef] [PubMed]
[5] Patsalos, P.N., Spencer, E.P. and Berry, D.J. (2018) Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. Therapeutic Drug Monitoring, 40, 526-548. [Google Scholar] [CrossRef] 
[6] Ference, B.A., Kastelein, J.J.P. and Catapano, A.L. (2020) Lipids and Lipoproteins in 2020. JAMA, 324, 595-596. [Google Scholar] [CrossRef] [PubMed]
[7] Skålén, K., Gustafsson, M., Rydberg, E.K., et al. (2002) Subendothe-lial Retention of Atherogenic Lipoproteins in Early Atherosclerosis. Nature, 417, 750-754. [Google Scholar] [CrossRef] [PubMed]
[8] Ference, B.A., Ginsberg, H.N., Graham, I., et al. (2017) Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. European Heart Journal, 38, 2459-2472. [Google Scholar] [CrossRef] [PubMed]
[9] Tietge, U.J. (2014) Hyperlipidemia and Cardiovascular Disease: In-flammation, Dyslipidemia, and Atherosclerosis. Current Opinion in Lipidology, 25, 94-95. [Google Scholar] [CrossRef] 
[10] 李俊, 张明, 陈夏. 抗癫痫药物与癫痫患者动脉粥样硬化关系研究进展[J]. 实用医学杂志, 2013, 29(5): 836-838.
[11] Schaftenaar, F., Frodermann, V., Kuiper, J. and Lut-gens, E. (2016) Atherosclerosis: The Interplay between Lipids and Immune Cells. Current Opinion in Lipidology, 27, 209-215. [Google Scholar] [CrossRef] 
[12] Tabas, I., Williams, K.J. and Borén, J. (2007) Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications. Circulation, 116, 1832-1844. [Google Scholar] [CrossRef] 
[13] Nezu, T., Hosomi, N., Aoki, S. and Matsumoto, M. (2016) Carotid Intima-Media Thickness for Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 23, 18-31. [Google Scholar] [CrossRef] [PubMed]
[14] Naqvi, T.Z. and Lee, M.S. (2014) Carotid Intima-Media Thickness and Plaque in Cardiovascular Risk Assessment. JACC: Cardiovascular Imaging, 7, 1025-1038. [Google Scholar] [CrossRef] [PubMed]
[15] Eirís, J.M., Lojo, S., Del Río, M.C., et al. (1995) Effects of Long-Term Treatment with Antiepileptic Drugs on Serum Lipid Levels in Children with Epilepsy. Neurology, 45, 1155-1157. [Google Scholar] [CrossRef] 
[16] Yamamoto, Y., Terada, K., Takahashi, Y., et al. (2016) Influence of Antiepileptic Drugs on Serum Lipid Levels in Adult Epilepsy Patients. Epilepsy Research, 127, 101-106. [Google Scholar] [CrossRef] [PubMed]
[17] Mintzer, S., Skidmore, C.T., Rankin, S.J., et al. (2012) Con-version from Enzyme-Inducing Antiepileptic Drugs to Topiramate: Effects on Lipids and C-Reactive Protein. Epilepsy Research, 98, 88-93. [Google Scholar] [CrossRef] [PubMed]
[18] Mintzer, S. and Mattson, R.T. (2009) Should En-zyme-Inducing Antiepileptic Drugs Be Considered First-Line Agents? Epilepsia, 50, 42-50. [Google Scholar] [CrossRef] [PubMed]
[19] Kim, D.W., Lee, S.Y., Shon, Y.M., et al. (2013) Effects of New Antiepileptic Drugs on Circulatory Markers for Vascular Risk in Patients with Newly Diagnosed Epilepsy. Epilep-sia, 54, e146-e149. [Google Scholar] [CrossRef] [PubMed]
[20] 吴冬燕, 朱国行. 抗癫痫药物的分类、作用机制与不良反应[J]. 上海医药, 2015(9): 3-7.

为你推荐